Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Exuzides

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
European Radiology|December 5, 2025
Letter to the Editor: Clarifying interpretation of cancer detection utility from whole-body MRIYosef Chodakiewitz, Daniel J Durand, Alex Exuzides
Biostatistics (Oxford, England)|August 23, 2003
Predictive influence in the accelerated failure time modelEdward J Bedrick, Alex Exuzides, Wesley O Johnson, et al.
Journal of Medical Economics|March 8, 2019
Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in EnglandLinda Harris, Sophie Graham, Sharon MacLachlan, et al.
Journal of Medical Economics|July 16, 2021
Reply: Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691-697Linda Harris, Sophie Graham, Sharon MacLachlan, et al.
BMC Neurology|May 9, 2022
A retrospective longitudinal cohort study of the clinical burden in myasthenia gravisLinda Harris, Sophie Graham, Sharon MacLachlan, et al.
Journal of Medical Economics|April 21, 2021
Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims databaseAlex Exuzides, Ning Wu, Daniel Sheinson, et al.
JACC. Cardiovascular Imaging|June 15, 2010
A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agentAlex Exuzides, Michael L Main, Chris Colby, et al.
Brain Sciences|February 25, 2022
Understanding the Burdens Associated with Huntington's Disease in Manifest Patients and Care Partners-Comparing to Parkinson's Disease and the General PopulationAlex Exuzides, Joana E Matos, Anisha M Patel, et al.
Vascular Health and Risk Management|September 21, 2011
COSEHC global vascular risk management quality improvement program: rationale and designCarlos M Ferrario, Michael A Moore, William Bestermann, et al.
Neuroepidemiology|April 28, 2022
Epidemiology of Huntington's Disease in the United States Medicare and Medicaid PopulationsAlex Exuzides, Sheila R Reddy, Eunice Chang, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
European Radiology|December 5, 2025
Letter to the Editor: Clarifying interpretation of cancer detection utility from whole-body MRIYosef Chodakiewitz, Daniel J Durand, Alex Exuzides
Biostatistics (Oxford, England)|August 23, 2003
Predictive influence in the accelerated failure time modelEdward J Bedrick, Alex Exuzides, Wesley O Johnson, et al.
Journal of Medical Economics|March 8, 2019
Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in EnglandLinda Harris, Sophie Graham, Sharon MacLachlan, et al.
Journal of Medical Economics|July 16, 2021
Reply: Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691-697Linda Harris, Sophie Graham, Sharon MacLachlan, et al.
BMC Neurology|May 9, 2022
A retrospective longitudinal cohort study of the clinical burden in myasthenia gravisLinda Harris, Sophie Graham, Sharon MacLachlan, et al.
Journal of Medical Economics|April 21, 2021
Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims databaseAlex Exuzides, Ning Wu, Daniel Sheinson, et al.
JACC. Cardiovascular Imaging|June 15, 2010
A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agentAlex Exuzides, Michael L Main, Chris Colby, et al.
Brain Sciences|February 25, 2022
Understanding the Burdens Associated with Huntington's Disease in Manifest Patients and Care Partners-Comparing to Parkinson's Disease and the General PopulationAlex Exuzides, Joana E Matos, Anisha M Patel, et al.
Vascular Health and Risk Management|September 21, 2011
COSEHC global vascular risk management quality improvement program: rationale and designCarlos M Ferrario, Michael A Moore, William Bestermann, et al.
Neuroepidemiology|April 28, 2022
Epidemiology of Huntington's Disease in the United States Medicare and Medicaid PopulationsAlex Exuzides, Sheila R Reddy, Eunice Chang, et al.
Pageof 3